ArticlePeerJ2022

Downregulation of the enhancer of zeste homolog 1 transcriptional factor predicts poor prognosis of triple-negative breast cancer patients.

Wei Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.